Lee Ainslie Maverick Capital
Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EA
Electronic Arts
EA
|
+$96.5M |
| 2 |
GFL Environmental
GFL
|
+$92.9M |
| 3 |
QuidelOrtho
QDEL
|
+$79.1M |
| 4 |
Astera Labs
ALAB
|
+$73.9M |
| 5 |
Natera
NTRA
|
+$60.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$307M |
| 2 |
Constellation Brands
STZ
|
+$86.1M |
| 3 |
Domino's
DPZ
|
+$76.7M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$73.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 32.34% |
| 2 | Technology | 17.7% |
| 3 | Healthcare | 16.82% |
| 4 | Financials | 10.98% |
| 5 | Real Estate | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Elevance Health
ELV
$86.9B
| – | – |
-2,057
| Closed | -$970K |
|
452
Eastman Chemical
EMN
$8.47B
| – | – |
-4,614
| Closed | -$414K |
|
453
Enbridge
ENB
$110B
| – | – |
-8,176
| Closed | -$295K |
|
454
Eaton
ETN
$163B
| – | – |
-2,067
| Closed | -$498K |
|
455
Edwards Lifesciences
EW
$51.8B
| – | – |
-2,977
| Closed | -$227K |
|
456
Exelon
EXC
$45.1B
| – | – |
-5,664
| Closed | -$203K |
|
457
FTI Consulting
FCN
$4.3B
| – | – |
-1,574
| Closed | -$313K |
|
458
Fidelity National Information Services
FIS
$21.3B
| – | – |
-15,059
| Closed | -$905K |
|
|
FITB
459
Fifth Third Bancorp
FITB
$49.7B
| – | – |
-12,758
| Closed | -$440K |
|
460
Five Below
FIVE
$13.8B
| – | – |
-14,397
| Closed | -$3.07M |
|
461
National Beverage
FIZZ
$3.03B
| – | – |
-25,478
| Closed | -$1.27M |
|
|
FL
462
DELISTED
Foot Locker
FL
| – | – |
-49,466
| Closed | -$1.54M |
|
463
Frontdoor
FTDR
$5.69B
| – | – |
-13,066
| Closed | -$460K |
|
464
Fortinet
FTNT
$113B
| – | – |
-10,139
| Closed | -$593K |
|
465
H.B. Fuller
FUL
$3.16B
| – | – |
-4,929
| Closed | -$401K |
|
466
Golar LNG
GLNG
$5.31B
| – | – |
-8,844
| Closed | -$203K |
|
467
Corning
GLW
$129B
| – | – |
-10,248
| Closed | -$312K |
|
468
Alphabet (Google) Class A
GOOGL
$4.22T
| – | – |
-23,498
| Closed | -$3.28M |
|
469
Genuine Parts
GPC
$18.5B
| – | – |
-6,593
| Closed | -$913K |
|
470
Goldman Sachs
GS
$303B
| – | – |
-2,311
| Closed | -$892K |
|
471
Gates Industrial Corp
GTES
$6.56B
| – | – |
-31,755
| Closed | -$426K |
|
472
IBM
IBM
$222B
| – | – |
-13,532
| Closed | -$2.21M |
|
473
Idexx Laboratories
IDXX
$43.9B
| – | – |
-1,481
| Closed | -$822K |
|
|
BRSL
474
Brightstar Lottery PLC
BRSL
$2.21B
| – | – |
-17,488
| Closed | -$479K |
|
475
Infosys
INFY
$48.4B
| – | – |
-36,253
| Closed | -$666K |
|
Similar funds
Lee Ainslie's Q1 2024 Portfolio in Review
As of Q1 2024, Lee Ainslie held 573 positions worth $5.32B, up 6.9% from $4.98B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Lee Ainslie withdrew a net $210M in Q1 2024, closing 168 positions and reducing 68 holdings. Its most notable exit was Immunogen Inc, an estimated $73.9M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Lee Ainslie opened a new position in Electronic Arts worth $93.2M.
- Lee Ainslie's largest Q1 2024 buy was Electronic Arts: 702,830 shares worth $93.2M.
- Lee Ainslie added most to Starbucks in Q1 2024, an estimated $51.2M increase.
- Lee Ainslie's biggest Q1 2024 reduction was Coupang, cutting an estimated $307M.
- Lee Ainslie fully exited Immunogen Inc in Q1 2024, selling an estimated $73.9M.
- Lee Ainslie's ten largest holdings make up 45% of its $5.32B portfolio in Q1 2024.
- Lee Ainslie opened 225 new positions and closed 168 in Q1 2024.
- Lee Ainslie's portfolio value rose 6.9% quarter-over-quarter to $5.32B.
Based on Maverick Capital's 13F filing for Q1 2024, filed 15 May 2024.